Literature DB >> 7096458

Use of 2-deoxy-D[1-11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects.

M Reivich, A Alavi, A Wolf, J H Greenberg, J Fowler, D Christman, R MacGregor, S C Jones, J London, C Shiue, Y Yonekura.   

Abstract

The deoxyglucose technique for the measurement of local cerebral glucose metabolism (LCMRgl) has been widely applied in animals utilizing 14C-deoxyglucose and in humans employing 18F-fluorodeoxyglucose. Repeat studies in humans over a relatively brief period of time have not been possible because of the 110-min half-life of fluorine-18. With the synthesis of 11C-deoxyglucose it has now become possible to utilize this short-lived (20 min) tracer for the measurement of LCMRgl and to determine its variability within subjects over a 2-h period. The kinetic rate constants for 11C-deoxyglucose were determined for gray and white matter and found to be very similar to those for 18F-fluorodeoxyglucose, suggesting that these two analogues of glucose have similar affinities for the facilitated transport system and are similar substrates for hexokinase in the brain. The coefficient of variation of repeated measurements of LCMRgl in a series of six normal subjects was 5.5% to 8.7% for various gray matter structures and 9.7% and 14.0% for white matter structures. The pattern of cerebral metabolic rates is relatively constant in a given individual when the conditions of the study are unchanged. The ability to make repeat measurements in the same subject reduces the variance due to between-subject differences, allowing smaller changes in LCMRgl to be detected with confidence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096458     DOI: 10.1038/jcbfm.1982.32

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  13 in total

1.  Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures.

Authors:  S M Schaefer; H C Abercrombie; K A Lindgren; C L Larson; R T Ward; T R Oakes; J E Holden; S B Perlman; P A Turski; R J Davidson
Journal:  Hum Brain Mapp       Date:  2000-05       Impact factor: 5.038

2.  Effect of nicotine on brain activation during performance of a working memory task.

Authors:  M Ernst; J A Matochik; S J Heishman; J D Van Horn; P H Jons; J E Henningfield; E D London
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study.

Authors:  W Guenther; J D Brodie; E J Bartlett; S L Dewey; F A Henn; N D Volkow; K Alper; A Wolkin; R Cancro; A P Wolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

4.  Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.

Authors:  A Wolkin; B Angrist; A Wolf; J Brodie; B Wolkin; J Jaeger; R Cancro; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.

Authors:  P Maquet; D Dive; E Salmon; R von Frenckel; G Franck
Journal:  Eur J Nucl Med       Date:  1990

6.  Synthesis and biodistribution of 2-deoxy-2-[18F]fluoro-D-glucopyranosyl [18F]fluoride in mice.

Authors:  C Y Shiue; C D Arnett; A P Wolf
Journal:  Eur J Nucl Med       Date:  1984

7.  75,77Br- and 123I-analogues of D-glucose as potential tracers for glucose utilisation in heart and brain.

Authors:  G Kloster; P Laufer; W Wutz; G Stöcklin
Journal:  Eur J Nucl Med       Date:  1983

8.  11C-2-deoxy-D-glucose: synthesis and preliminary comparison with 11C-D-glucose as a tracer for cerebral energy metabolism in PET studies.

Authors:  S Stone-Elander; J L Nilsson; G Blomqvist; E Ehrin; L Eriksson; B Garmelius; T Greitz; P Johnström; I Sjögren; L Widén
Journal:  Eur J Nucl Med       Date:  1985

9.  Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration.

Authors:  N D Volkow; J D Brodie; A P Wolf; B Angrist; J Russell; R Cancro
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

10.  Improved synthesis and low-temperature autoradiographic evaluation of 18F-n-fluoropropane as a myelin tracer for positron emission tomography.

Authors:  M Diksic; B Kodery; K Sako; W Feindel; Y L Yamamoto
Journal:  Eur J Nucl Med       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.